Abstract | BACKGROUND: Noninfectious granulomatous skin diseases are inflammatory disorders of unknown aetiology which are often recalcitrant to common anti-inflammatory treatment regimens. Recently, in several case reports, fumaric acid esters (FAE) have proved beneficial in granulomatous skin diseases, but studies on a larger collection of consecutive patients have not yet been performed. OBJECTIVES: To investigate the therapeutic efficacy of FAE for the treatment of granulomatous skin diseases. PATIENTS AND METHODS: RESULTS: Three patients discontinued treatment within 4 weeks because of side-effects. Of the remaining 29 patients, 18 patients responded to treatment with FAE. Marked improvement or complete clearance was seen in seven patients. We observed a slight to moderate improvement in 11 patients, and 11 patients did not respond. In patients showing a complete remission, the maximum effect was observed after 8.5 months (SD +/-6 months, range 3-20 months). In two patients with systemic sarcoidosis, the pulmonary changes improved in parallel with the skin. Side-effects were usually mild and resolved spontaneously upon dose reduction or discontinuation of the therapy. CONCLUSIONS: The data presented here indicate that FAE may be considered for the treatment of recalcitrant granulomatous skin disease.
|
Authors | K Breuer, R Gutzmer, B Völker, A Kapp, T Werfel |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 152
Issue 6
Pg. 1290-5
(Jun 2005)
ISSN: 0007-0963 [Print] England |
PMID | 15948995
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Esters
- Fumarates
- fumaric acid
|
Topics |
- Adolescent
- Adult
- Aged
- Cheilitis
(drug therapy)
- Drug Administration Schedule
- Esters
- Female
- Fumarates
(administration & dosage, therapeutic use)
- Granuloma Annulare
(drug therapy)
- Granuloma, Giant Cell
(drug therapy)
- Humans
- Male
- Middle Aged
- Necrobiosis Lipoidica
(drug therapy)
- Retrospective Studies
- Sarcoidosis
(drug therapy)
- Skin Diseases
(drug therapy)
|